Ondine Capital, a venture capital firm focused on frontier technologies, has announced the first close of its third U.S.
Catch up on AI news updates, including unconfirmed leaks for Claude Sonnet 6 and the official launch of OpenAI's GPT-6 Cyber ...
Recursion Pharmaceuticals (NASDAQ:RXRX) has counted Nvidia as an investor since 2023 when Jensen Huang's company invested ...
Together AI builds an agentic compiler to try and bring recursive self improvement capabilities to open source models.
Recursion Q3 2026 earnings: clinical wins for REC-4881 and REC-1245, Sanofi progress, and cash runway to 2029.
Anthropic, the company behind Claude AI, has warned that its artificial intelligence models could soon reach a stage where AI could become capable of ...
Recursion said it expects to launch its first registrational trial in the second half of this year for its lead candidate REC-4881 based on talks with the FDA, after the oral familial adenomatous ...
A Google DeepMind and Stanford study finds simple shapes like a red heart can push AI models such as GPT-5.4 and Claude ...
Anthropic's amended S-1 says future models may soon hit its threshold for AI-driven recursive self-improvement. No current ...
In an amended S-1/A filing submitted to the SEC on November 2, 2026, Anthropic warned of the possibility that it is ...
In the latest filing related to Anthropic's IPO, the company says RSI could be arriving "imminently," which would mean self-improving AI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results